Ten year mortality trends among Israeli pancreatic ductal adenocarcinoma (PDAC) patients.

e16222Background: PDAC is one of the most lethal cancers, with 5-year overall survival (OS) ranging from 3-8%, and median survival of 6-11 months for patients with metastatic disease. We aimed to e...